相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year multicenter study
Diane Bruyere et al.
MODERN PATHOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy
K. Wakeham et al.
CLINICAL ONCOLOGY (2021)
Microbiome and pancreatic ductal adenocarcinoma
Annemilai Tijeras-Raballand et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2021)
Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients
Cindy Neuzillet et al.
SCIENTIFIC REPORTS (2021)
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman et al.
SCIENCE (2020)
Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer
G. Serna et al.
ANNALS OF ONCOLOGY (2020)
Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients
Ellen Teresa Boehm et al.
SCIENTIFIC REPORTS (2020)
The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma
Zigui Chen et al.
CANCERS (2020)
Survival and Operative Outcomes After Salvage Surgery for Recurrent or Persistent Anal Cancer
In Ja Park et al.
ANNALS OF COLOPROCTOLOGY (2020)
Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1
Chamutal Gur et al.
ONCOIMMUNOLOGY (2019)
Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma
Kensuke Yamamura et al.
CLINICAL CANCER RESEARCH (2019)
Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity
Jiao Wu et al.
TRANSLATIONAL ONCOLOGY (2019)
The gut microbiota influences anticancer immunosurveillance and general health
Bertrand Routy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Fusobacterium nucleatum and colorectal cancer: A review
Fu-Mei Shang et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Biomarkers in anal cancer: from biological understanding to stratified treatment
Christopher M. Jones et al.
BRITISH JOURNAL OF CANCER (2017)
Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP)
Laurence Moureau-Zabotto et al.
DIGESTIVE AND LIVER DISEASE (2017)
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Kosuke Mima et al.
GUT (2016)
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
Wulfran Cacheux et al.
BRITISH JOURNAL OF CANCER (2016)
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer
Katsuhiko Nosho et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
Chamutal Gur et al.
IMMUNITY (2015)
Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis
Kei Mitsuhashi et al.
ONCOTARGET (2015)
Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2014)
Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines
Otilia Leon et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials
Carine A. Bellera et al.
EUROPEAN JOURNAL OF CANCER (2013)
Signature patterns of human papillomavirus type 16 in invasive anal carcinoma
Severine Valmary-Degano et al.
HUMAN PATHOLOGY (2013)
Anal cancer - a review
Sajad Ahmad Salati et al.
INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS (2012)
分享论文
